Examinando por Autor "Prieto, Juan Carlos"
Mostrando 1 - 2 de 2
Resultados por página
Opciones de ordenación
Ítem Consenso de expertos colombianos sobre recomendaciones basadas en evidencia para el diagnóstico, tratamiento y seguimiento del raquitismo hipofosfatémico ligado al cromosoma X (RHLX)(Research Square Company, 2023) Cárdenas Aguilera, Juan Guillermo; Medina Orjuela, Adriana; Isabel Meza, Adriana; Prieto, Juan Carlos; Zarante Bahamón, Ana María; Cáceres Mosquera, Jimena Adriana; Mejía Gaviria, Natalia; Serrano Gayubo, Ana Katherina; Baquero Rodríguez, Richard; Chacón Acevedo, Kelly; Guerrero Tinoco, Gustavo Adolfo; Uribe Ríos, Alejandro; García Rueda, María Fernanda; Abad Londoño, Verónica; Nossa Almanza, Sergio Alejandro; Aroca Martínez, Gustavo; Román González, Alejandro; Endo Cáceres, Jorge Alberto; Llano Linares, Juan Pablo; Florenzano Valdes, Pablo; Diaz Curiel, Manuel; Vaisbich, María Helena; Zanchetta, María Belén; Guerra Hernández, Norma Elizabeth; Stefano, Eduardo Enrique; Brunetto, OscarBackground: X-linked hypophosphatemic rickets is a hereditary disease that generates alterations in bone mineral homeostasis. The morbidity of the condition has been variable in previous decades and even contradictory, probably due to the definition of the case and the diagnostic confirmation. Our propose was to generate evidence-informed recommendations for the diagnosis, treatment, and follow-up of patients with suspected or diagnosed XLHR. Results: After the screening and selection process for 1041 documents, 38 were included to answer the questions raised by the developer group. 97 recommendations about the diagnosis, treatment, and follow-up of patients with suspected or diagnosed XLHR were approved by the experts consulted through modified Delphi consensus. The quality of the evidence was low. Conclusions: The recommendations proposed here will allow early and timely diagnosis of X-linked hypophosphatemic rickets, while optimizing resources for its treatment and follow-up and help clarify the burden of disease and improve health outcomes for this population.Ítem Expert consensus on evidence-based recommendations for the diagnosis, treatment, and follow-up of X-linked hypophosphatemic rickets (XLH)(Asociación Colombiana de Nefrología e Hipertensión Arterial, 2024) Cárdenas-Aguilera, Juan Guillermo; Medina-Orjuela, Adriana; Meza-Martínez, Adriana Isabel; Prieto, Juan Carlos; Zarante-Bahamón, Ana María; Cáceres-Mosquera, Jimena Adriana; Mejía-Gaviria, Natalia; Serrano-Gayubo, Ana Katherina; Baquero-Rodríguez, Richard; Chacón-Acevedo, Kelly; Guerrero-Tinoco, Gustavo Adolfo; Uribe-Ríos, Alejandro; García-Rueda, María Fernanda; Abad-Londoño, Verónica; Nossa-Almanza, Sergio Alejandro; Aroca-Martínez, Gustavo; Román-González, Alejandro; Endo-Cáceres, Jorge Alberto; Llano-Linares, Juan Pablo; Florenzano, Pablo; Díaz-Curiel, Manuel; Vaisbich, María Helena; Zanchetta, María Belén; Guerra-Hernández, Norma Elizabeth; Enrique Stefano, Eduardo; Brunetto, OscarIntroduction: X-linked hypophosphatemic rickets is a hereditary condition causing disruptions in bone mineral homeostasis. The morbidity associated with this condition has exhibited variability in previous decades, possibly stemming from variations in case definitions and diagnostic confirmation procedures. Objective: Our aim was to generate evidence-informed recommendations for the diagnosis, treatment, and follow-up of patients with suspected or diagnosed XLH. Methodology: Integration of a literature review with a modified Delphi method, guided by expert consensus. Results: Following the screening and selection of 1041 documents, 41 were chosen to address the queries posed by the developer group. Experts, consulted through a modified Delphi consensus, endorsed 97 recommendations on the diagnosis, treatment, and follow-up of patients with suspected or diagnosed XLH. Notably, the quality of the evidence was deemed to be low. Conclusions: The recommendations proposed here will allow early and timely diagnosis of Xlinked hypophosphatemic rickets, while optimizing resources for its treatment and follow-up. In addition, it will help clarify the burden of the disease and improve health outcomes for this population.